Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Charles Briscoe

Psychiatry Corbin, KY Medical Doctor

NPI 1033245055 CMS profile 228662

1 Trillium Way, Corbin, KY 40701

Open in the dashboard

General payments

$2,056

115 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Charles Briscoe of Corbin, KY is reported in the CMS Open Payments database as having received $2,056 across 115 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 80th percentile of Psychiatry profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $320 17
2024 General $430 22
2023 General $303 15
2022 General $270 16
2021 General $99 5
2020 General $141 8
2019 General $494 32

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Charles Briscoe
  • Psychiatry median
  • Middle half of Psychiatry
  • National median

In program year 2025, general payments to Charles Briscoe were reported at $320. Among 14,155 Psychiatry profiles paid that year, the median was $180 and the middle half received between $58 and $685.

Show as a table
Year Charles Briscoe Psychiatry median Middle half National median
2019 $494 $184 $59–$605 $163
2020 $141 $119 $36–$372 $114
2021 $99 $143 $43–$576 $132
2022 $270 $153 $50–$590 $149
2023 $303 $170 $56–$651 $160
2024 $430 $179 $57–$673 $164
2025 $320 $180 $58–$685 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Alkermes, Inc. $502 25 payments
  2. Janssen Pharmaceuticals, Inc $433 25 payments
  3. Lundbeck LLC $155 9 payments
  4. AbbVie, Inc. $128 7 payments
  5. Otsuka America Pharmaceutical, Inc. $106 6 payments
  6. Sunovion Pharmaceuticals Inc. $106 7 payments
  7. Teva Pharmaceuticals USA, Inc. $91 4 payments
  8. E.R. Squibb & Sons, L.L.C. $79 4 payments
  9. Indivior Inc. $66 4 payments
  10. Allergan Inc. $64 4 payments
  11. Other $327 20 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $2,056 115 payments
Products named General payments · program years 2019–2025
  1. ARISTADA Cns $484 24 payments
  2. ARISTADA Cns $484 24 payments
  3. ARISTADA Cns $384 19 payments
  4. ARISTADA Cns $384 19 payments
  5. ARISTADA INITIO $353 18 payments
  6. SPRAVATO $350 20 payments
  7. LYBALVI $230 11 payments
  8. ABILIFY MAINTENA $194 11 payments
  9. INVEGA SUSTENNA $142 9 payments
  10. VRAYLAR $129 8 payments
  11. Other $1,117 64 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 31 drugs

Part D claims

1,056

Median for Psychiatry: 574

Drug cost

$107,973

Median for Psychiatry: $27,624

Branded share of claims

18.9%

Median for Psychiatry: 17%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Rexulti Brexpiprazole Brand 19 $43,568
Vraylar Cariprazine Hcl Brand 24 $32,747
Lybalvi Olanzapine/Samidorphan Malate Brand 11 $17,123
Clozapine Generic 20 $1,842
Bupropion Xl Bupropion Hcl Brand 49 $1,651
Olanzapine Generic 44 $1,372
Alprazolam Er Alprazolam Brand 39 $1,370
Quetiapine Fumarate Generic 70 $1,100
Mirtazapine Generic 123 $815
Duloxetine Hcl Generic 25 $660

The 10 drugs with the highest cost, of 31 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 20,488 Part D prescribers listed as Psychiatry; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 10 billing codes

Paid by Medicare

$25,665

Medicare's payments for the services billed

Medicare patients

56

Average age 63

Services billed

362

27 women, 29 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Depression 75%
Diabetes 48%
Arthritis 38%
COPD 32%
Ischemic heart disease 29%
Chronic kidney disease 23%
Heart failure 20%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 15 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
ABILIFY MAINTENA
  • Lundbeck LLC $72
  • Otsuka America Pharmaceutical, Inc. $11
$83 — —
VRAYLAR
  • AbbVie, Inc. $63
$63 24 —
ARISTADA
  • Alkermes, Inc. $48
$48 — —
INVEGA SUSTENNA
  • Janssen Pharmaceuticals, Inc $38
$38 — —
UZEDY
  • Teva Pharmaceuticals USA, Inc. $26
$26 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 15 in the dashboard with a free account

Records

115 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Psychiatry in Kentucky

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record